CAMEO+ eventCORPORATE2026-05-07馃嚚馃嚟
Roche agrees to acquire US-based PathAI in major deal
source: Roche -> target: PathAI
On 2026-05-07, Roche agreed to acquire U.S.-based PathAI for $750 million upfront plus up to $300 million in milestone payments. PathAI, based in Boston, is expected to join Roche's diagnostics division when the deal closes in the second half of 2026.
0.26Significance4.0Magnitude0.3Systemic0.5Market1Articles
Location
ZurichEuropeSwitzerlandEurope47.377, 8.542
Story Links